Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Peter Auguste* (Corresponding Author), Jill Colquitt, Martin Connock, Emma Loveman, Rachel Court, Olga Ciccarelli, Carl Counsell, Xavier Armoiry
Dive into the research topics of 'Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal'. Together they form a unique fingerprint.